We are live on ! Find out more
OBIO icon

Orchestra BioMed
OBIO

23 hedge funds and large institutions have $56.4M invested in Orchestra BioMed in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

19.04% less ownership

Funds ownership: 69.84% → 50.8% (-19%)

60% less capital invested

Capital invested by funds: $140M → $56.4M (-$83.5M)

63% less funds holding

Funds holding: 62 → 23 (-39)

78% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 9

91% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 43

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
23
Holders Change
-39
Holders Change %
-62.9%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
2
Reduced
9
Closed
43
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$9.91M
2
TCM
Tang Capital Management
California
+$3.89M
3
RL
RPO LLC
Connecticut
+$240K
4
Deutsche Bank
Deutsche Bank
Germany
+$149K
5
UBS Group
UBS Group
Switzerland
+$23.1K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.35M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.97M
3
SCM
Saba Capital Management
New York
-$7.34M
4
AC
Amitell Capital
Singapore
-$5.98M
5
SC
Sculptor Capital
New York
-$5.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
51
Picton Mahoney Asset Management
Ontario, Canada
– -$781K -78,507 Closed
HI
52
HBK Investments
Texas
– -$690K -69,237 Closed
MC
53
Meteora Capital
Florida
– -$603K -60,572 Closed
KL
54
KIM LLC
Kansas
– -$462K -46,394 Closed
AI
55
Arena Investors
New York
– -$434K -43,526 Closed
SSA
56
Schonfeld Strategic Advisors
New York
– -$428K -42,998 Closed
MF
57
Magnetar Financial
Illinois
– -$414 -41,556 Closed
Alyeska Investment Group
58
Alyeska Investment Group
Illinois
– -$249K -25,000 Closed
Nomura Holdings
59
Nomura Holdings
Japan
– -$205K -20,502 Closed
CCM
60
CAAS Capital Management
New York
– -$202K -20,300 Closed
SC
61
Sagefield Capital
Texas
– -$182K -18,300 Closed
DFCM
62
Dark Forest Capital Management
Puerto Rico
– -$176K -17,651 Closed
6CM
63
683 Capital Management
New York
– -$100K -10,000 Closed
RCM
64
Rivernorth Capital Management
Florida
– -$100K -10,000 Closed
CCM
65
Context Capital Management
California
– -$3K -308 Closed
Northwestern Mutual Wealth Management
66
Northwestern Mutual Wealth Management
Wisconsin
– -$2K -154 Closed
1 2
3

OBIO Hedge Fund Activity: Q3 2022 in Review

23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Orchestra BioMed (OBIO) for Q3 2022, worth a combined $56.4M — down 60% from $140M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of OBIO and 4 opened new positions — a net loss of 39 holders — while 9 trimmed existing stakes and 2 added.

The largest buyer was RTW Investments, opening a new position worth an estimated $9.91M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $9.35M sold.

  • 23 institutional investors held Orchestra BioMed (OBIO) as of Q3 2022, down from 62 in Q2 2022.
  • Funds reported $56.4M of Orchestra BioMed stock for Q3 2022, down 60% quarter-over-quarter.
  • 4 funds opened new Orchestra BioMed positions in Q3 2022 and 43 closed out, a net change of -39 holders.
  • The largest Orchestra BioMed buyer in Q3 2022 was RTW Investments, an estimated $9.91M added.
  • The largest Orchestra BioMed seller in Q3 2022 was D.E. Shaw & Co, an estimated $9.35M sold.

Based on aggregated 13F filings for Q3 2022.